Public Company News

CBAK Energy Reports First Quarter 2024 Unaudited Financial Results

- Expected net income from the battery business to be between RMB220 million and RMB250 million for the full year of 2024 DALIAN, China, May 10, 2024 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading lithium-ion battery manufacturer and electr...

2024-05-10 18:00 2916

Yalla Group Limited to Report First Quarter 2024 Financial Results on May 20, 2024 Eastern Time

DUBAI, UAE, May 10, 2024 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largestMiddle East and North Africa (MENA)-based online social networking and gaming company, today announced that it will report its unaudited financial results for the first quarter 2024 af...

2024-05-10 18:00 2778

ZEEKR Intelligent Technology Holding Limited Announces Pricing of its Initial Public Offering

HANGZHOU, China, May 10, 2024 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK), a fast-growing battery electric vehicle ("BEV") technology company, today announced the pricing of its initial public offering of 21,000,000 American Depositary Shares...

2024-05-10 17:16 3124

Acer Announces April Consolidated Revenues at NT$17.85 Billion, Marking 10 Months of Consecutive YoY Growth

TAIPEI, May 10, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for April atNT$17.85 billion with 29.1% growth year-on-year (YoY), and achieving 10 consecutive months of YoY growth. Consolidated revenues for year-to-April reachedNT$76.68 billion with 15.7% growth ...

2024-05-10 15:43 3410

Star Asia Group to Acquire 100% of Minacia Co. Ltd, a Leading Domestic Hotel Operator

TOKYO, May 9, 2024 /PRNewswire/ -- Star Asia Group is pleased to announce that it has entered into a share transfer agreement with Minacia Co., Ltd. ("Minacia") onApril 26, 2024, to acquire 100% of the shares of Minacia. 1. Reason for Share Acquisition Star Asia Group believes that the Japanese ...

2024-05-10 10:00 1811

Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost

* Adalimumab-aaty will be priced at an 85% discount to HUMIRA® (adalimumab) * Branded and unbranded versions of Celltrion USA's adalimumab biosimilar help provide more affordable options for patients JERSEY CITY, N.J., May 9, 2024 /PRNewswire/ -- CelltrionUSA announced today that adalimumab-aa...

2024-05-10 07:41 1369

Dogness Announces Entry into US$5.0 Million Private Placement

PLANO, Texas, May 9, 2024 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it entered into a private placement transact...

2024-05-10 04:45 2825

NaaS Technology Inc. Reports Unaudited 2024 First Quarter Financial Results

BEIJING, May 9, 2024 /PRNewswire/ -- NaaS Technology Inc. ("NaaS" or the "Company") (Nasdaq: NaaS), the first U.S. listed EV charging service company in China, today announced its unaudited financial results for the first quarter endedMarch 31, 2024. First Quarter 2024 Financial Highlights: * ...

2024-05-10 04:30 3209

Sunyard Will Showcase Innovative Payment Technology at Seamless Middle East 2024

HANGZHOU, China, May 9, 2024 /PRNewswire/ -- Sunyard Technology, the leading global payment solution provider, will participate in Seamless Middle East 2024 in the World Trade Center, Dubai from May 14 to 16, showcasing featured payment products based on Sunyard's latest technology and advanced s...

2024-05-09 22:00 1522

Taoping Launches New Enhanced AI-Powered Smart Terminal

SHENZHEN, China, May 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a developer of innovative smart cloud platform services and solutions, new media and artificial intelligence solutions, today unveiled a new, upgraded AI-powered smart terminal. This cutting-edge platform int...

2024-05-09 20:30 3220

Origin Agritech Receives GMO Safety Certificate for its Triple Stack Maize

Commercial Rollout to Begin Shortly BEIJING, May 9, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the issuance of a GMO safety certificate for its transgenic maize, BBL2-2, marking a signif...

2024-05-09 20:30 1720

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

The latest innovation is anticipated to increase collection volume without increasing collection time * Rika's individualized nomogram, iNomi, can enable plasma donors to donate the right amount of plasma on any given day based on height, weight and hematocrit. * The Rika Plasma Donation Sys...

2024-05-09 20:00 1375

Globe's Hapag Movement reaches global audience with new international partner Project PEARLS

MANILA, Philippines, May 9, 2024 /PRNewswire/ -- Globe, a leading telecommunications company inthe Philippines, broadens the reach of the Hapag Movement, its advocacy to alleviate involuntary hunger, as it teams up with US-based non-profit Project PEARLS, opening up the program to a global audien...

2024-05-09 20:00 1618

Emeren to Release First Quarter 2024 Financial Results on May 23, 2024

STAMFORD, Conn., May 9, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com ) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced that it will report its unaudited financial results for the first quarter ...

2024-05-09 18:00 2738

Acer Announces Q1 2024 Net Income at NT$1.20 Billion, Up 133.4% Year-on-year

Margins for gross profit, operating income, and net income all grow year-on-year TAIPEI, May 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its financial results for the first quarter of 2024. Consolidated revenues reached NT$58.83 billion, up 12.2% year-on-year (YoY); gross profits reac...

2024-05-09 17:13 2784

Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, May 9, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of clobetasol...

2024-05-09 15:00 2093

Xiao-I Corporation Announces Strategic Partnership with Top Hong Kong Insurance Company to Enhance AI-Driven Customer Service

SHANGHAI, May 8, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading artificial intelligence company, is proud to announce a strategic partnership in April with a prominentHong Kong insurance company. This collaboration aims to integrate Xiao-I's advanced...

2024-05-09 09:53 2877

SK hynix Develops Next-Generation Mobile NAND Solution ZUFS 4.0

* Mass production of industry's best-performing product for on-device AI smartphones to begin in 3Q * Performance degradation over time improved, while lifetime increased by 40% * SK hynix to expand leadership in AI memory space with strong presence in NAND solutions following success of HBM...

2024-05-09 08:00 1463

Zepp Health Corporation to Report First Quarter 2024 Financial Results on May 20, 2024

Earnings Call Scheduled for 7:00 p.m. ET on May 20, 2024 MILPITAS, Calif., May 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will repo...

2024-05-08 20:00 2885

TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain

* The study (NCT05138562) met its primary endpoint of change of dysmenorrhea (menstrual pain) score from baseline to 12 weeks compared to placebo across all tested doses (120 mg, 240 mg, and 320 mg)  * Merigolix is expected to emerge as a best-in-class treatment based on its excellent pain re...

2024-05-08 20:00 1238
1 ... 81828384858687 ... 772

Week's Top Stories